Blog
Elevating Knowledge Around Cannabis, Wellness, and Innovation.
New York Cannabis Taxes in 2025: What the 3.15% Medical Excise and 9%/13% Adult-Use Taxes Mean for Patient Affordability
Why this matters Taxes shape the final price patients and consumers pay at the counter. New York’s 2024–2025 changes lowered the tax burden on medical cannabis and simplified adult-use taxes—two shifts that can influence affordability in different ways. The medical...
Delta-8 Under Fire (Again): FDA Warning Letters and a Patchwork of State Crackdowns—How to Identify Safe, Compliant Products
Why you’re hearing so much about Delta-8 Delta-8 THC (usually converted from hemp-derived CBD) remains in legal limbo. In 2025, the FDA continued issuing warning letters over safety/labeling violations, while many states moved to restrict or ban intoxicating hemp...
Cannabis & Insomnia: What an 18-Month PLOS Mental Health Study Means for Patients (and What It Doesn’t)
The headline A new peer-reviewed study following patients with primary insomnia for up to 18 months found sustained improvements in subjective sleep quality and health-related quality of life among those prescribed cannabis-based medicinal products. But it’s an...
Schedule III on the Horizon? What Federal Rescheduling Would Change for Patients, Pricing, and 280E in New York
The U.S. Department of Justice has proposed moving cannabis from Schedule I to Schedule III. If finalized, this would not legalize adult-use federally—but it would likely remove the punishing 280E tax burden going forward and could gradually lower patient costs in New...
The Federal Shift: How Moving Cannabis to Schedule III Could Transform Patient Care in 2025
1. Why 2025 Is a Turning Point Picture this: you walk into your primary-care clinic, discuss chronic neuropathic pain, and leave with a formal prescription for medical-grade cannabis—a prescription your insurance carrier may soon partly reimburse. That...
Microdosing Medical Cannabis in 2025: A Precision Guide for Consistent Relief — Without the High
1. The 2.5 mg Revolution “Less is more” isn’t just a wellness meme—it’s the medical-cannabis headline of 2025. Google search interest in microdosing cannabis skyrocketed 1,250 % between 2015 and 2023 and has kept climbing as Schedule III rescheduling inches closer to...
From Myrcene to Limonene: 2025 Research Unlocks Terpene-Driven, Condition-Specific Cannabis Relief
1. Terpenes, 2025’s Medical-Cannabis Headline Open a jar of Burning Bush’s Regenerative OG and you’ll catch citrus, forest-pine, maybe a hint of lavender candy. Those aromas come from terpenes—volatile plant compounds now credited with turning “plain THC” into...
Growing Green: How Regenerative Cannabis Farms Elevate Purity — and Planet Health — in 2025
1. Beyond “Organic”: Why Regeneration Became 2025’s Buzzword Organic regulations tell growers what not to do (no synthetic pesticides, no GMO seed). Regenerative farming goes further: it restores soil biology, closes nutrient loops, and draws carbon out of the air....